Developing New Treatments for Tourette Syndrome: Therapeutic Trials With Modulators of Glutamatergic Neurotransmission

NCT01018056 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

39

Enrollment

OTHER

Sponsor class

Conditions

Tourette Syndrome

Interventions

DRUG: D-serine
DRUG: Riluzole
DRUG: Placebo

Sponsor

Johns Hopkins University

Collaborators

[object Object]